81. Neuroleptic Malignant Syndrome And Mivacurium: A Safe Alternative To Succinylcho neuroleptic malignant syndrome (NMS) and malignant hyperthermia (MH) may have acommon pathogenic mechanism; therefore, it has been suggested that known http://www.cja-jca.org/cgi/content/abstract/41/9/845

HOME HELP FEEDBACK SUBSCRIPTIONS ... TABLE OF CONTENTS This Article Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager ... Cited by other online articles PubMed PubMed Citation Articles by Kelly, D. Articles by Brull, S. J. ARTICLES Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine? D Kelly and SJ Brull Department of Anesthesiology, Yale University School of Medicine, New Haven, CT 06510. Neuroleptic malignant syndrome (NMS) and malignant hyperthermia (MH) may have a common pathogenic mechanism; therefore, it has been suggested that known triggering agents for MH (such as succinylcholine) should be avoided in patients with NMS. Electroconvulsive therapy (ECT) continues to play a major therapeutic role in contemporary psychiatry, and succinylcholine has been the muscle relaxant of choice in attenuating violent muscle contractions induced by ECT. Mivacurium is a non-depolarizing muscle

82. Item Detail - Article: Treatment Of Neuroleptic Malignant Syndrome - Malignant H MHAUS is the only association in the United States dedicated to the control ofmalignant hyperthermia (MH), a lifethreatening genetic disorder. http://www.mhaus.org/index.cfm/fuseaction/eShop.ItemGroupDetail/ItemGroupPK/F01E

Neuroleptic Malignant Syndrome Information Service North American MH Registry of MHAUS Log In - MHAUS Associates Only My eShop Cart Item Detail - Article: Treatment of Neuroleptic Malignant Syndrome Article: Treatment of Neuroleptic Malignant Syndrome Inv# Item Detail Price/Unit Qty. Buy NMS-TREAT Reprinted article $0.00 / EACH

83. Item Detail - Brochure: Neuroleptic Malignant Syndrome Information Service - Mal MHAUS is the only association in the United States dedicated to the control ofmalignant hyperthermia (MH), a lifethreatening genetic disorder. http://www.mhaus.org/index.cfm/fuseaction/eShop.ItemGroupDetail/ItemGroupPK/EFD0

Neuroleptic Malignant Syndrome Information Service North American MH Registry of MHAUS Log In - MHAUS Associates Only My eShop Cart Item Detail - Brochure: Neuroleptic Malignant Syndrome Information Service Brochure: Neuroleptic Malignant Syndrome Information Service This brochure describes the NMSIS organization: Hotline Web site Educational materials Inv# Item Detail Price/Unit Qty. Buy NMSINFO Brochure on NMSIS $0.50 / EACH

84. U.S. Pharmacist AGE/INCIDENCE ASSOCIATION NOT FOUND IN neuroleptic malignant syndrome As diagnostic criteria for neuroleptic malignant syndrome typically encompass a http://www.uspharmacist.com/index.asp?show=article&page=8_1405.htm

85. Obstetrics & Gynecology -- Sign In Page BACKGROUND neuroleptic malignant syndrome can be a serious neurologic neuroleptic malignant syndrome is a potentially lethal complication of treatment http://www.greenjournal.org/cgi/content/full/98/5/906

HOME HELP FEEDBACK SUBSCRIPTIONS ... SEARCH QUICK SEARCH: [advanced] Author: Keyword(s): Year: Vol: Page: This item requires a subscription to Full Text Neuroleptic Malignant Syndrome in Pregnancy Russell et al. Obstet Gynecol. This Article Abstract Full Text (PDF) Alert me when this article is cited ... Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager PubMed PubMed Citation Articles by Russell, C. S. Articles by Calhoun, B. To view this item, select one of the options below: Sign In User Name Sign in without cookies. Can't get past this page? Help with Cookies. Need to Activate? Password Forgot your user name or password? Purchase Short-Term Access Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$20.00 Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired. Sign Up Subscribe to the Journal - Subscribe to the print and/or online journal.

86. Neuroleptic Malignant Syndrome Articles, Support Groups, And Resources neuroleptic malignant syndrome articles, support groups, and resources for patientsfrom Med Help International (www.medhelp.org) http://www.medhelp.org/HealthTopics/Neuroleptic_Malignant_Syndrome.html

[Health Topics A-Z] A B C D ... Z Neuroleptic Malignant Syndrome Medical Glossary: NEUROLEPTIC MALIGNANT SYNDROME Ask The Doctor Forums Neuroleptic Malignant Syndrome (Mental Health Forum) Med Help International Search Medical Forums / Message Boards ... Site Map Revised: 9/7/2005

87. NEUROLEPTIC MALIGNANT SYNDROME neuroleptic malignant syndrome This describes the combination of catatonicrigidity, stupor, unstable blood pressure, fever, profuse sweating, sweating, http://www.medhelp.org/glossary2/new/GLS_3312.HTM

NEUROLEPTIC MALIGNANT SYNDROME - This describes the combination of catatonic rigidity, stupor , unstable blood pressure fever , profuse sweating, sweating, and incontinence as a reaction to antipsychotic agents ( phenothiazines ) in therapeutic doses. Med Help International Library Search Ask the Doctor Forums The medical glossary has been made possible by a generous donation from:

88. Early Recognition Of Neuroleptic Malignant Syndrome During Traumatic Bain Injury Kadyan, V., Colachis, S., DePalma, L., Samderson, J., Mysiw, W. Early recognitionof neuroleptic malignant syndrome during traumatic bain injury http://www.tbindc.org/registry/searchresults.php?searchparam=publication/id/635

89. Neuroleptic Malignant Syndrome Induced By Haloperidol Following Traumatic Brain Wilkinson, W., Meythaler, J., GuinRenfroe, S. neuroleptic malignant syndromeinduced by haloperidol following traumatic brain injury. http://www.tbindc.org/registry/searchresults.php?searchparam=publication/id/922

90. Neuroleptic-induced Extrapyramidal Symptoms With Fever: Heterogeneity Of The 'ne Neurolepticinduced extrapyramidal symptoms with fever heterogeneity ofthe neuroleptic malignant syndrome . Levinson DF, Simpson GM http://www.meb.uni-bonn.de/cgi-bin/mycite?ExtRef=MEDL/86322351

91. Facilitating Prompt Diagnosis And Treatment Of The Neuroleptic Malignant Syndrom Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome.Nierenberg D, Disch M, Manheimer E, et al. http://www.meb.uni-bonn.de/cgi-bin/mycite?ExtRef=MEDL/92036048

92. Directory Of Open Access Journals Title, Olanzapineassociated neuroleptic malignant syndrome Is there an Key words, neuroleptic malignant syndrome; serotonin syndrome; olanzapine http://www.doaj.org/abstract?id=82890&toc=y

93. Arquivos De Neuro-Psiquiatria - Translate this page neuroleptic malignant syndrome case report of a recurrence related to olanzapine.ABSTRACT - The neuroleptic malignant syndrome (NMS) consists in an http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1998000500022

94. Sao Paulo Medical Journal - CONTEXT A case of neuroleptic malignant syndrome and acute respiratory neuroleptic malignant syndrome is a disease that is difficult to diagnose. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802003000300007

95. Antidepressants Facts: Serotonin Syndrome SSRI's, SSNRI's from the neuroleptic malignant syndrome because the symptoms are so similar.The neuroleptic malignant syndrome is a serious condition brought on by the http://www.antidepressantsfacts.com/serotonin-syndrome-ADF.htm

By Charly Groenendijk Back to Side-Effects The Netherlands The Serotonin Syndrome "Who does Not Know the Truth, is simply a Fool... Yet who Knows the Truth and Calls it a Lie, is a Criminal." - In "Galileo Galilei" by Berthold Brecht (1898-1956) T ake notice that also non SSRI anti-depressants (and even Ritalin) may interact (primary or secondary) with the serotonergic (or serotoninergic) system in the brain Protect Your Children Against Bush's (July 2004) Forced U.S. "Mental Health Screening" Program The Federal PPRA Act of 1998 Serotonin Syndrome T he Serotonin Syndrome is a hyperserotonergic state which is a very dangerous and a potentially fatal side effect of serotonergic enhancing drugs which can have multiple psychiatric and non-psychiatric symptoms. This is a toxic condition which requires heightened clinical awareness in order to prevent, recognize, and treat the condition promptly. Promptness is vital because, as we just mentioned, the serotonin syndrome can be fatal and death from this side effect can come very rapidly. This syndrome is a toxic hyperserotonergic state whose rate of incidence is unknown, but is on the rise. This disorder, brought on by excessive levels of serotonin, is difficult to distinguish from the neuroleptic malignant syndrome because the symptoms are so similar. The neuroleptic malignant syndrome is a serious condition brought on by the use of the neuroleptic drugs.

96. Neuroleptic Malignant Syndrome (Treatment Guide) neuroleptic malignant syndrome DEFINITION A lifethreatening idiosyncratic reactioncharacterized by muscle rigidity and hyperthermia, related to acute http://www.intox.org/databank/documents/treat/treate/trt37_e.htm

NEUROLEPTIC MALIGNANT SYNDROME DEFINITION A life-threatening idiosyncratic reaction characterized by muscle rigidity and hyperthermia, related to acute dopamine depletion, either from the use of neuroleptic drugs or of dopamine antagonists, or the withdrawal of dopamine agonists. TOXIC CAUSES Exposure to therapeutic doses of potent neuroleptic drugs (eg, haloperidol, fluphenazine) or the sudden cessation of dopamine agonists such as amantidine. Reported risk factors include dehydration and the concurrent use of lithium and tricyclic antidepressants. CLINICAL FEATURES Extreme hyperpyrexia, lead-pipe muscular rigidity, autonomic dysfunction (tachycardia, elevated or fluctuating blood pressure), sweating, tachypnoea, respiratory failure, altered mental status (confusion, delirium, stupor and coma), extrapyramidal signs (e.g. cogwheel hypertonia). Acute myoglobinuric renal failure may occur. The condition is fatal in up to 12 % of cases DIFFERENTIAL DIAGNOSIS Anticholinergic poisoning Catatonia CNS infections CNS mass lesions Ethanol or sedative-hypnotic drug withdrawal Extrapyramidal symptoms with fever Heat-stroke (environmental or exertional) Malignant hyperthermia Metal fume fever Psychiatric disorders Septicaemia Strychnine poisoning Thyroid storm Tetanus Tetany RELEVANT INVESTIGATIONS Laboratory tests are generally non-specific, but may be used to exclude alternative diagnoses. Arterial blood gases - metabolic acidosis is usually present. Creatinine phosphokinase activity - commonly elevated; marked elevations may indicate a serious risk of acute renal failure. CT scan of the head may be obtained to rule out CNS lesions. Electrolytes - hyperkalaemia, hyper- or hyponatraemia, hypocalcaemia. Liver function tests are not characteristic, but may be elevated. Lumbar puncture to rule out CNS infection. Renal function - urea, creatinine. Standard fever work-up to rule out infections. Urinalysis - urinary myoglobin or myoglobin casts may be present White blood cell count - leukocytosis may be present, (between 12,000 and 30,000 /mm

97. Indian Journal Of Psychiatry neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious neuroleptic malignant syndrome (NMS) (Delay Deniker, 1968) is a rare, http://www.ijponline.org/JanMar2003/article7.html

Vol. 45 No. 1 January 2003 Indian Journal of Psychiatry, 2003, Home Risk Factors in Neuroleptic Malignant Syndrome VINAY GUPTA, RAKESH MAGON, B.P. MISHRA, G.B.S. SIDHU, RANJIV MAHAJAN ABSTRACT Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important. Top

98. CUADERNOS DE NEUROLOGIA Translate this page Caroff S, Mann S, Campbell E. neuroleptic malignant syndrome. Adverse Drug ReactBull. Buckley PF, Hutchinson M. neuroleptic malignant syndrome. http://escuela.med.puc.cl/publ/Cuadernos/2003/Neuroleptico.html

Factores de riesgo Tratamiento El paciente debe ingresar a una unidad de cuidados intensivos y se debe suspender inmediatamente los NL. De ser necesario reiniciar los NL, se deben esperar al menos dos semanas de resuelto el SNM, para intentar evitar una recurrencia del cuadro. Idealmente se debe utilizar un NL de menor potencia, de todas formas el riesgo de recurrencia es de un 15%. Morbimortalidad Conclusiones Referencias: Delay J, Deniker P. Sur quelque erreurs de prescription des medicament psychiatrique. Bull Mem Soc Med Hop Paris. 1965; 116: 487. Caroff S, Mann S, Campbell E. Neuroleptic malignant syndrome. Adverse Drug React Bull. 2001; 209: 799-802. Caroff S, Rosenberg H, Mann S, Campbell E, Sullivan K. Neuroleptic malignant syndrome in the perioperative setting. Am J Anesthesiol. 2001; 28: 387-93. Rodintzky R. Drug-induced disorders in children. Sem in Pediatr Neurol. 2003; 10: 80-7 Carbone J. The neuroleptic malignant syndrome and serotonin syndrome. Emerg Med Clin North Am. 2000; 18: 317-25. Henderson V, Wooten C. Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade? Neurology. 1981; 31: 132-7.

99. Current Psychiatry Online Probable or definite neuroleptic malignant syndrome cases associated with Source neuroleptic malignant syndrome Information Service hotline http://www.currentpsychiatry.com/article_pages.asp?AID=704&UID=187

100. The American Journal Of The Medical Sciences - UserLogin Acute Hypernatremia and neuroleptic malignant syndrome in Parkinson Disease neuroleptic malignant syndrome is a clinical syndrome characterized by fever http://www.amjmedsci.com/pt/re/ajms/fulltext.00000441-199907000-00011.htm

LWWOnline LOGIN eALERTS REGISTER ... Archive You are attempting to access protected content. To access this content please login using an established account or create/activate an account. If you have already created/ activated an online account, please login below: User Name: Password: Note: passwords are CASE SENSITIVE If you are a new user or guest visiting an LWWonline site for the first time, please complete the new account setup process to view or purchase content. Forgot your password? Subscribe Renewal Information Subscribe to RSS feed utrdc-pt01 Release 4.0

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 5     81-100 of 104    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20